These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31568312)

  • 41. Prevention of Thyroidectomy Scars in Asian Adults With Low-Level Light Therapy.
    Park YJ; Kim SJ; Song HS; Kim SK; Lee J; Soh EY; Kim YC
    Dermatol Surg; 2016 Apr; 42(4):526-34. PubMed ID: 26981718
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination of surgical subcision and intralesional corticosteroid injection as a cost-effective and minimally invasive treatment for postoperative adhesive thyroidectomy scars.
    Lee JH; Kim TH; Lee YS; Chang HS; Park CS; Roh MR
    Dermatol Surg; 2013 Dec; 39(12):1822-6. PubMed ID: 24206263
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Donor Site Aesthetic Enhancement With Preoperative Botulinum Toxin in Forehead Flap Nasal Reconstruction.
    Zelken J; Yang SY; Chang CS; Chang CJ; Yang JY; Chuang SS; Chen HC; Hsiao YC
    Ann Plast Surg; 2016 Nov; 77(5):535-538. PubMed ID: 26418784
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Botulinum Toxin Type A Inhibits α-Smooth Muscle Actin and Myosin II Expression in Fibroblasts Derived From Scar Contracture.
    Chen M; Yan T; Ma K; Lai L; Liu C; Liang L; Fu X
    Ann Plast Surg; 2016 Sep; 77(3):e46-9. PubMed ID: 25144422
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early postoperative single treatment ablative fractional lasing of Mohs micrographic surgery facial scars: a split-scar, evaluator-blinded study.
    Sobanko JF; Vachiramon V; Rattanaumpawan P; Miller CJ
    Lasers Surg Med; 2015 Jan; 47(1):1-5. PubMed ID: 25559589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized controlled trial of the embrace advanced scar therapy device to reduce incisional scar formation.
    Longaker MT; Rohrich RJ; Greenberg L; Furnas H; Wald R; Bansal V; Seify H; Tran A; Weston J; Korman JM; Chan R; Kaufman D; Dev VR; Mele JA; Januszyk M; Cowley C; McLaughlin P; Beasley B; Gurtner GC
    Plast Reconstr Surg; 2014 Sep; 134(3):536-546. PubMed ID: 24804638
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Research advances on application of botulinum toxin type A in scar prevention and treatment].
    Yu Z; Ren P; Zhang H; Chen H; Ma FX
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2022 Apr; 38(4):385-388. PubMed ID: 35462519
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multidose Botulinum Toxin A for Intralaryngeal Injection: A Cost Analysis.
    Gilbert MR; Young VN; Smith LJ; Rosen CA
    J Voice; 2019 Mar; 33(2):159-161. PubMed ID: 29307768
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of Botulinum Toxin Type A in Improving Scar Quality and Wound Healing: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Guo X; Song G; Zhang D; Jin X
    Aesthet Surg J; 2020 Apr; 40(5):NP273-NP285. PubMed ID: 31155638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of hypertrophic scars with intralesional botulinum toxin type A injections: a preliminary report.
    Xiao Z; Zhang F; Cui Z
    Aesthetic Plast Surg; 2009 May; 33(3):409-12. PubMed ID: 19357910
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of Skin Physiology Change and Safety After Intradermal Injections With Botulinum Toxin: A Randomized, Double-Blind, Placebo-Controlled, Split-Face Pilot Study in Rosacea Patients With Facial Erythema.
    Kim MJ; Kim JH; Cheon HI; Hur MS; Han SH; Lee YW; Choe YB; Ahn KJ
    Dermatol Surg; 2019 Sep; 45(9):1155-1162. PubMed ID: 30730346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of Botulinum Toxin Type A for Prevention of Post-Mastectomy Scar in Transmen: A Prospective, Randomized Study.
    Winayanuwattikun W; Vachiramon V; Rattananukrom T; Palakornkitti P; Sitpahul N
    Toxins (Basel); 2023 Oct; 15(11):. PubMed ID: 37999499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of Botulinum Toxin A in Preventing Recurrence Keloids: Double Blinded Randomized Controlled Trial Study: Intraindividual Subject.
    Pruksapong C; Yingtaweesittikul S; Burusapat C
    J Med Assoc Thai; 2017 Mar; 100(3):280-6. PubMed ID: 29911784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early post-operative use of Botulinum toxin type A in prevention of scar after mammoplasty and abdominoplasty.
    Motamed S; Bakhshi R; Hedayatyanfard K; Haddadi NS; Khalili A; Bayat G; Tavakoli-Far B; Roeintan A
    Australas J Dermatol; 2022 Feb; 63(1):111-113. PubMed ID: 34699057
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of botulinum toxin pretreatment on laser resurfacing results: a prospective, randomized, blinded trial.
    Zimbler MS; Holds JB; Kokoska MS; Glaser DA; Prendiville S; Hollenbeak CS; Thomas JR
    Arch Facial Plast Surg; 2001; 3(3):165-9. PubMed ID: 11497500
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Local Injection of Botulinum Toxin Type A to Prevent Postoperative Scar.
    Chen S; Yang Y; Zhang D; Liu Y; Li Y
    J Craniofac Surg; 2020; 31(2):440-443. PubMed ID: 31977704
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fissurectomy Combined with High-Dose Botulinum Toxin Is a Safe and Effective Treatment for Chronic Anal Fissure and a Promising Alternative to Surgical Sphincterotomy.
    Barnes TG; Zafrani Z; Abdelrazeq AS
    Dis Colon Rectum; 2015 Oct; 58(10):967-73. PubMed ID: 26347969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A prospective, randomized clinical trial of transverse versus longitudinal incisions for trigger finger release.
    Kazmers NH; Holt D; Tyser AR; Wang A; Hutchinson DT
    J Hand Surg Eur Vol; 2019 Oct; 44(8):810-815. PubMed ID: 31272265
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Validation of Fespixon in Postoperative Scar Cosmesis Using Quantitative Digital Photography Analysis.
    Huang TR; Chen SG; Chen JC; Liu SC
    Aesthet Surg J; 2023 May; 43(6):NP427-NP437. PubMed ID: 36624624
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Botulinum toxin type a inhibits connective tissue growth factor expression in fibroblasts derived from hypertrophic scar.
    Xiao Z; Zhang M; Liu Y; Ren L
    Aesthetic Plast Surg; 2011 Oct; 35(5):802-7. PubMed ID: 21455826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.